Clinical Trial Update: BAY86-5046 (Betaseron), Non Interventional Studies

View source ↗

Summary

Bayer's non-interventional studies of Betaseron (interferon beta-1b) for multiple sclerosis have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED